However, with the recognition of NUT midline carcinoma and emergence of novel NUT monoclonal antibodies, case numbers are now increasing in all ages and organs, including extra-midline sites (resulting in the name NUT carcinoma) [2]. This evidence concerns the gene NUTM1 and nut midline carcinoma.